
1. emerg infect dis. 2017 mar;23(3):517-520. doi: 10.3201/eid2303.161363.

molecular evidence drug resistance asymptomatic malaria infections,
myanmar, 2015.

nyunt mh, shein t, zaw nn, han ss, muh f, lee sk, han jh, thant kz, han et, kyaw 
mp.

artemisinin resistance containment myanmar initiated 2011 after
artemisinin-resistant plasmodium falciparum malaria reported. molecular
evidence suggests asymptomatic malaria infections harboring drug resistance 
genes present among residents myanmar artemisinin resistance
containment zone. evidence supports efforts eliminate hidden
infections.

doi: 10.3201/eid2303.161363 
pmcid: pmc5382746
pmid: 28221121  [indexed medline]

